CClinicalTrials.gg
Not yet recruitingNCT07182162Updated Dec 17, 2025

Point-of-Care Ultrasound (PoCUS) Teleeducation Curriculum for Hospital-at-home Care

An interventional study of Remote supervision + simulation in Educational Problems, sponsored by National Taiwan University Hospital. Not yet recruiting at 1 site in Taiwan. Open to participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-17.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

Since July 2024, the National Health Insurance Administration (NHIA) has been implementing a pilot Hospital-at-Home (HAH) Acute Care Program to curb hospital admissions. Point-of-Care Ultrasound (PoCUS) is considered the most promising imaging tool for this model. Replicating the hospital's familiar environment-its staffing patterns, diagnostic workflows, and medication protocols-in a patient's home or nursing facility is almost impossible, posing a major challenge to care teams. Medical-simulation training offers a solution, yet current PoCUS courses remain organ-based and lack scenario-based simulations that prepare physicians for HAH practice.

This two-year study will create a PoCUS curriculum and outcome-assessment tools tailored to HAH, adapting previously validated Entrustable Professional Activities (EPA) instruments to three HAH scenarios: pneumonia, urinary tract infection, and soft-tissue infection. Year 1 will develop scenario-based simulation courses and matching EPA tools, and train peer instructors who receive full PoCUS instruction for the three scenarios. Year 2 will randomly assign learners to compare two teaching models-peer training with remote supervision and scenario simulation versus traditional PoCUS training-evaluated with an Objective Structured Clinical Examination (OSCE) scored by EPA forms across multiple domains.

The project aims to establish normative standards for PoCUS training and assessment in HAH, confirm the feasibility of peer training with remote supervision, and provide a platform to train HAH medical teams nationwide, including those in rural areas.

Read the detailed description

Background

PoCUS has evolved from hospital-based imaging to bedside diagnostic support, enabling rapid, problem-oriented assessments across trauma, shock, dyspnea, and resuscitation scenarios as portable devices matured in image quality and accessibility.

Recent medical education trends emphasize competency-based medical education (CBME), milestones, and EPAs, requiring structured assessment of indications, image acquisition, interpretation, and integration into management for skill-intensive technologies such as ultrasound.

Near-peer training can scale instruction without loss of effectiveness compared with faculty-led teaching, while remote supervision and simulation address logistical limits. However, online environments can attenuate nonverbal cues, underscoring the need for purposeful instructional design and validated evaluation tools.

Taiwan's National Health Insurance (NHI) launched a HAH pilot program in July 2024 focusing on acute infections-pneumonia, urinary tract infection (UTI), and soft tissue infection-where portable diagnostics and PoCUS can substitute or complement in-hospital imaging for timely home-based decisions.

Clinicians transitioning from hospital workflows to patients' homes and care facilities face new operational constraints, motivating scenario-based, high-fidelity simulation to rehearse dynamic conditions and multi-skill tasks that mirror real HAH care.

Objectives

The study aims to compare the effectiveness of a PoCUS curriculum using near-peer training with remote supervision and high-fidelity scenario simulation versus traditional on-site, in-person PoCUS teaching in the HAH context.

The study also aims to determine whether remote OSCE combined with EPA assessments are consistent with in-person evaluations and feasible for high-stakes skill appraisal. EPA-based assessment levels across four domains-Indication, Acquisition, Interpretation, and Integration-are anchored to OSCE cases aligned with HAH pneumonia, urinary tract infection, and soft tissue infection scenarios.

Methods

This is a two-year, prospective, randomized educational intervention study.

  • Year 1: Development of HAH-focused scenario-based curricula; design of OSCE and EPA tools through expert consensus; and training of near-peer instructors who undergo rehearsal teaching with faculty observation and immediate feedback to qualify for Year 2 delivery roles.
  • Year 2: Randomization of Post-Graduate Year (PGY) residents to receive either traditional PoCUS instruction (didactics plus on-site faculty-supervised hands-on training) or the new model (didactics plus near-peer hands-on training with remote supervision and scenario simulation). Outcomes will be measured by OSCE performance scored using EPA instruments.

Participants

The target population comprises PGY residents, internal medicine residents, and family medicine residents at National Taiwan University Hospital who volunteer to enroll, with a planned Year 2 sample size of approximately 100 participants.

Inclusion criteria are the above-mentioned residency trainees aged 20 years or older. Exclusion criteria include unwillingness to participate.

Outcomes

  • Primary outcomes: Learning outcomes between traditional and near-peer training with remote supervision and simulation. Learning outcomes include self-assessment questionnaires and EPA-based OSCE scores.
  • Secondary outcomes:

    1. Technology Acceptance Model (TAM) survey: Learners' feedback on the new curriculum, collected after the PoCUS course and before OSCE testing.
    2. OSCE survey: A post-OSCE survey on learner feedback regarding the examination itself.
    3. Inter-rater variability: Agreement between remote and in-person EPA-based OSCE ratings to establish feasibility and equivalence of the remote assessment tool.
02

Conditions studied

  • Educational Problems

Keywords

  • ultrasound
  • peer teaching
  • remote supervision
  • simulation
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

■ PGY, internal medicine, and family medicine residents at National Taiwan University Hospital.

Exclusion criteria

Exclusion Criteria:

■Unwillingness to participate in the study.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Remote supervision + Simulation

    This group will experience didactics plus near-peer hands-on with remote supervision and scenario simulation (lecture + on-site near-peer instructor hands-on + simulation). The PoCUS teacher will not be physically present but will supervise remotely via video conferencing to monitor and communicate in real-time.

    Other: Remote supervision + simulation

  • No intervention
    Control

    This group will follow the conventional teaching model, didactics plus on-site faculty-supervised hands-on (lecture + on-site teacher supervised hands-on).

Interventions

  • OtherRemote supervision + simulation

    teacher use remote supervision to assist peer training Hospital-at-Home scenario simulation

06

What researchers measure

Primary outcomes

  1. OSCE total and subscale scores on EPA-based PoCUS

    The effectiveness of the curriculum will be evaluated approximately one month after completing the PoCUS course for both the experimental and control groups, using OSCE assessments incorporating EPA constructs. The OSCE will be evaluated independently by two reviewers(on site and remote), with the final score calculated as the average of their individual assessments. Students' performance will be analyzed based on their total OSCE scores as well as their scores for each construct of the EPA.

    Time frame: 1 month

Secondary outcomes

  1. Technology Acceptance Model (TAM) questionnaire total and subscale scores

    Learners' feedback on the new curriculum, using the Technology Acceptance Model (TAM) will be collected after the PoCUS course and before the OSCE testing.

    Time frame: 1 month

  2. Post-OSCE survey score

    After the OSCE, a survey on the feedback on OSCE test will also be conducted.

    Time frame: 1 month

  3. Inter-rater reliability of EPA-based OSCE ratings

    Agreement between remote and in-person EPA-based OSCE ratings to establish feasibility and equivalence of this remote tool

    Time frame: 1 month

07

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data (IPD) regarding the survey of TAM model and feedbak on OSCE test will be shared.

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07182162
Lead sponsor
National Taiwan University Hospital
Collaborators
National Science and Technology Council
Responsible party
National Taiwan University Clinical Trial Center (Attending physician, National Taiwan University Hospital, National Taiwan University Hospital) — Principal investigator
First posted
Sep 19, 2025
Start date
Apr 1, 2026 (estimated)
Primary completion
Oct 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Dec 17, 2025

Study contacts

National Taiwan University Hospital Research Ethics Committee
Contact
ntuhrec@ntuh.gov.tw
+886-2-23123456 ext. 263506
Nin-Chieh Hsu, MD, PhD
Contact
chesthsu@gmail.com
+886-972653088

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion